[OPLN] Owens Minor Patient Direct Apria Thesis 2026: Home Health Spin Off Compounder

Key Takeaways

• Owens & Minor Patient Direct/Apria (NASDAQ: OPLN), the headquartered Patient-Direct-Apria-Home-Health-and-Healthcare-Services + emerging-multi-cycle-Patient-Direct-Apria-Spin-Off-from-Owens-Minor leader, closes FY2025 with selected various aggregate revenue ~$2.55-2.85B (~3-8% YoY-reflecting Patient-Direct-Apria-Home-Health-Cycle + emerging-multi-cycle-Spin-Off-from-Owens-Minor), adjusted EBITDA ~$285-345M (~10-12% margins), adjusted EPS ~$0.85-1.30, net debt ~$1.10-1.40B (~3.5-4.5x leverage).
• President & CEO leadership-continuity-Post-Spin-Off-Owens-Minor leads FY2026 turning on Apria-Home-Health-Sleep-and-Respiratory-Therapy + emerging-multi-cycle-Patient-Direct-Home-Healthcare-Services + emerging-Home-Sleep-Apnea-CPAP-and-BiPAP-Cycle + emerging-Home-Oxygen-and-Respiratory-Therapy + emerging-Diabetes-Direct-Home-Delivery + emerging-Conservative-Debt-Paydown-Post-Spin-Off + Multi-Cycle-Patient-Direct-Strategy.
• Sector context: Health-Care + Patient-Direct-Apria-Home-Health-and-Healthcare-Services + emerging-multi-cycle-Patient-Direct-Apria-Spin-Off-from-Owens-Minor + emerging-Home-Sleep-Apnea-CPAP-and-Respiratory-Therapy-Cycle.

Company Background

Owens & Minor Patient Direct/Apria (NASDAQ: OPLN, formerly Apria-Inc), is a Patient-Direct-Apria-Home-Health-and-Healthcare-Services + emerging-multi-cycle-Patient-Direct-Apria-Spin-Off-from-Owens-Minor leader providing distinctive multi-cycle Apria-Home-Health-Sleep-and-Respiratory-Therapy + emerging-Patient-Direct-Home-Healthcare-Services + emerging-Home-Sleep-Apnea-CPAP-and-BiPAP-Cycle + emerging-Home-Oxygen-and-Respiratory-Therapy + emerging-Diabetes-Direct-Home-Delivery + emerging-Home-Negative-Pressure-Wound-Therapy services to substantial multi-cycle Home-Sleep-Apnea-CPAP-and-BiPAP-Patient + multi-cycle-emerging-Home-Oxygen-and-Respiratory-Therapy-Patient + multi-cycle-emerging-Diabetes-Direct-Home-Delivery-Patient + multi-cycle-emerging-Home-Negative-Pressure-Wound-Therapy-Patient + multi-cycle-emerging-Medicare-and-Medicaid-and-Commercial-Insurance-Payor customer base.

The company has distinctive multi-cycle Owens-Minor-Patient-Direct-Apria-and-Patient-Direct-Home-Health-and-Healthcare-Services heritage: founded 1979 as Apria-Home-Health-Pioneer + 1995-Apria-Healthcare-historical + 2008-Apria-Healthcare-Acquired-Blackstone-Take-Private + 2018-Apria-Healthcare-IPO-NASDAQ-Re-Listing-Post-Blackstone + 2021-Apria-Owens-Minor-Acquired-Owens-Minor-Reverse-Morris-Trust-like + 2024 substantial Owens-Minor-Patient-Direct-Apria-Spin-Off-Process-Initiated + Multi-Cycle-Patient-Direct-Strategic-Review-and-Spin-Off + 2024-2025 substantial Spin-Off-Process-Owens-Minor-Patient-Direct-Apria-Spin-Off-Anticipated-2025-2026 + Multi-Cycle-Patient-Direct-Home-Healthcare-Services-Pure-Play-Strategy; multi-cycle-disciplined-Patient-Direct-Apria-Home-Health-and-Healthcare-Services-Capital-Management; Patient-Direct-CEO-Post-Spin-Off-Owens-Minor + Multi-Cycle-Owens-Minor-Patient-Direct-Apria-Capital-Management leadership-continuity.

FY2025 closes with selected various aggregate revenue ~$2.55-2.85B (~3-8% YoY-reflecting Patient-Direct-Apria-Home-Health-Cycle + emerging-multi-cycle-Spin-Off-from-Owens-Minor + emerging-Home-Sleep-Apnea-CPAP-and-Respiratory-Therapy-Cycle), adjusted EBITDA ~$285-345M (~10-12% margins), adjusted EPS ~$0.85-1.30 (Patient-Direct-Apria-Home-Health-Spin-Off-Period-margin-execution), net debt ~$1.10-1.40B (~3.5-4.5x leverage), and ~75-78M shares outstanding under Patient-Direct-Apria-Post-Spin-Off-Leadership.

Deep-Dive 1 — Apria-Home-Health-Sleep-and-Respiratory-Therapy-and-Patient-Direct-Services

The Patient-Direct-Apria-Home-Health franchise deep-dive covers distinctive multi-cycle ~7,000-7,500 employees + ~Patient-Direct-Apria-Home-Health-and-Healthcare-Services-Operating-Footprint across US-National. Revenue mix: Home-Sleep-Apnea-CPAP-and-BiPAP-and-Respiratory-Therapy ~58-65% revenue (Home-Sleep-Apnea-CPAP-and-BiPAP-Devices-and-Supplies-Resupply + Home-Oxygen-and-Respiratory-Therapy + emerging-multi-cycle-Home-Sleep-Apnea-CPAP-Recurring-Resupply-Cycle) + Diabetes-Direct-and-Home-Negative-Pressure-Wound-Therapy ~22-28% revenue (Diabetes-Direct-Home-Delivery-Continuous-Glucose-Monitor-CGM-and-Insulin-Pump + Home-Negative-Pressure-Wound-Therapy + emerging-multi-cycle-Diabetes-Direct-Home-Delivery-Cycle) + Other-Home-Healthcare-Services-Adjacency ~10-15% revenue (Home-Healthcare-Services-Adjacency + emerging-multi-cycle-Patient-Direct-Home-Healthcare-Services).

Substantial multi-cycle Home-Sleep-Apnea-CPAP-and-BiPAP-Patient + multi-cycle-emerging-Home-Oxygen-and-Respiratory-Therapy-Patient + multi-cycle-emerging-Diabetes-Direct-Home-Delivery-Patient + multi-cycle-emerging-Home-Negative-Pressure-Wound-Therapy-Patient + multi-cycle-emerging-Medicare-and-Medicaid-and-Commercial-Insurance-Payor. 1979-Apria-Home-Health-Pioneer-founded + 2008-Apria-Healthcare-Acquired-Blackstone-Take-Private + 2018-Apria-Healthcare-IPO-NASDAQ-Re-Listing-Post-Blackstone + 2021-Apria-Owens-Minor-Acquired-Owens-Minor-Reverse-Morris-Trust-like + 2024-Owens-Minor-Patient-Direct-Apria-Spin-Off-Process-Initiated + 2024-2025-Spin-Off-Process transformational-platform, emerging-multi-cycle Patient-Direct-Apria-Spin-Off-from-Owens-Minor + emerging-Home-Sleep-Apnea-CPAP-and-Respiratory-Therapy-Cycle + emerging-Patient-Direct-Home-Healthcare-Services + emerging-Home-Sleep-Apnea-CPAP-Recurring-Resupply-Cycle + emerging-Diabetes-Direct-Home-Delivery-Cycle + emerging-Home-Negative-Pressure-Wound-Therapy + emerging-Conservative-Debt-Paydown-Post-Spin-Off structural-tailwinds. Competing in Patient-Direct-Apria-Home-Health space with AdaptHealth (AHCO ~Home-Sleep-Apnea-CPAP-and-Respiratory-Therapy-Largest-Independent), Lincare Holdings-acquired-Linde-Group-2012 (private-Linde-Subsidiary-Home-Oxygen-and-Respiratory-Therapy), Aerogen-private-Home-Sleep-Apnea-CPAP, Apria-Healthcare-pre-spin-off (Owens-Minor-Subsidiary-Patient-Direct-Apria), Quipt Home Medical (QIPT ~Home-Sleep-Apnea-CPAP-and-Respiratory-Therapy), VieMed Healthcare (VMD ~Home-Sleep-Apnea-CPAP-and-Respiratory-Therapy), Insulet (PODD ~Diabetes-Direct-Insulin-Pump-and-Pod-Adjacency-OmniPod), Dexcom (DXCM ~Diabetes-Direct-Continuous-Glucose-Monitor-CGM-Adjacency), Tandem Diabetes Care (TNDM ~Diabetes-Direct-Insulin-Pump-Adjacency), CCS Medical-acquired-AdaptHealth-2024 (AHCO-Subsidiary-Diabetes-Direct-Home-Delivery + Home-Sleep-Apnea-CPAP), Edgepark Medical Supplies-Cardinal-Health-acquired (CAH-Subsidiary-Home-Healthcare-Supplies + Diabetes-Direct), CCS Medical-AdaptHealth-Subsidiary + Multi-Cycle-Industry-Consolidation; and private-equity-Apollo-KKR-Blackstone-Carlyle-Bain-CD&R-EQT-Permira-CVC-Bridgepoint-Cinven-Ardian-TPG-Veritas-Genstar-Hellman-Friedman-Sun-Capital-Investindustrial-Roark-Capital-Linde-Group-Lincare.

Deep-Dive 2 — Patient-Direct-Apria-Post-Spin-Off-Leadership-and-2024-Spin-Off-Process-Capital-Allocation

The Patient-Direct-Apria-Post-Spin-Off-Leadership + 2024-Spin-Off-Process + multi-decade compounder thesis + 1979-Apria-Home-Health-Founded-and-2018-Apria-NASDAQ-Re-Listing-and-2021-Owens-Minor-Acquired-and-2024-Spin-Off-Process deep-dive covers Patient-Direct-Apria-Post-Spin-Off-Leadership + multi-cycle-Owens-Minor-Patient-Direct-Apria-Capital-Management leadership-continuity, 1979-Apria-Home-Health-Pioneer-founded + 2008-Apria-Healthcare-Acquired-Blackstone-Take-Private + 2018-Apria-Healthcare-IPO-NASDAQ-Re-Listing-Post-Blackstone + 2021-substantial-Apria-Owens-Minor-Acquired-Owens-Minor-Reverse-Morris-Trust-like + 2024-substantial-Owens-Minor-Patient-Direct-Apria-Spin-Off-Process-Initiated + Multi-Cycle-Patient-Direct-Strategic-Review-and-Spin-Off + 2024-2025-substantial-Spin-Off-Process-Owens-Minor-Patient-Direct-Apria-Spin-Off-Anticipated-2025-2026 + Multi-Cycle-Patient-Direct-Home-Healthcare-Services-Pure-Play-Strategy transformational-platform, multi-cycle-disciplined-Patient-Direct-Apria-Home-Health-and-Healthcare-Services-Capital-Management discipline, and no-dividend (Cash-Flow-Reinvested-in-Patient-Direct-Apria-Home-Health-and-Healthcare-Services-and-Conservative-Debt-Paydown-Post-Spin-Off) + multi-cycle-emerging-share-buyback-Post-Spin-Off-discretionary.

Track Sub-IG balance sheet (Ba2/BB to Ba1/BB+ ~3.5-4.5x leverage Patient-Direct-Apria-Home-Health-and-Healthcare-Services-and-Spin-Off-Capital-Structure + multi-cycle-emerging-Conservative-Debt-Paydown-Post-Spin-Off), multi-cycle-Owens-Minor-Patient-Direct-Apria-Capital-Management leadership-continuity, and emerging-strategic-acquisition-target optionality (Patient-Direct-Apria-Home-Health-M&A-Activity AdaptHealth, Lincare-Linde, VieMed Healthcare, Quipt Home Medical, Insulet, Dexcom, Tandem Diabetes Care, CCS Medical-AdaptHealth-acquired).

Capital Position + Balance Sheet

Capital position is Sub-IG (Ba2/BB to Ba1/BB+ 3.5-4.5x leverage Patient-Direct-Apria-Home-Health-and-Healthcare-Services-and-Spin-Off-Capital-Structure + multi-cycle-emerging-Conservative-Debt-Paydown-Post-Spin-Off). Capital allocation reflects no-dividend (Cash-Flow-Reinvested-in-Patient-Direct-Apria-Home-Health-and-Healthcare-Services-and-Conservative-Debt-Paydown-Post-Spin-Off), multi-cycle-emerging-share-buyback-Post-Spin-Off-discretionary, and multi-cycle-CapEx-Patient-Direct-Apria-Home-Health-Equipment-and-Operating-Footprint ($75-150M/yr).

Net-debt position ~$1.10-1.40B reflects multi-cycle-Patient-Direct-Apria-Home-Health-and-Healthcare-Services-and-Spin-Off-Capital-Structure-financing. 2024-Owens-Minor-Patient-Direct-Apria-Spin-Off-Process-Initiated + 2024-2025-Spin-Off-Process provides emerging-multi-cycle-Patient-Direct-Apria-Pure-Play-Home-Health-and-Healthcare-Services-and-Spin-Off-Capital-Discipline-Optionality.

Key Core Metrics

• Revenue: ~$2.55-2.85B (~3-8% YoY-reflecting Patient-Direct-Apria-Home-Health-Cycle)
• Adjusted EBITDA: ~$285-345M (~10-12% margins)
• Adjusted EPS: ~$0.85-1.30
• Net debt: ~$1.10-1.40B (~3.5-4.5x leverage)
• Shares outstanding: ~75-78M
• Dividend: None (Cash-Flow-Reinvested-in-Patient-Direct-Apria-Home-Health-and-Conservative-Debt-Paydown-Post-Spin-Off)
• Revenue mix: Home-Sleep-Apnea-CPAP-and-BiPAP-and-Respiratory-Therapy ~58-65% + Diabetes-Direct-and-Home-Negative-Pressure-Wound-Therapy ~22-28% + Other-Home-Healthcare-Services-Adjacency ~10-15%
• Patient-Direct-Apria-Spin-Off-from-Owens-Minor: Anticipated-2025-2026

Market Evaluation

At ~$14-22 per share, equity value ~$1.05-1.70B, EV ~$2.15-3.10B, providing ~11-19x EPS and ~7-10x EV/EBITDA. The market evaluation reflects emerging-multi-cycle Patient-Direct-Apria-Spin-Off-from-Owens-Minor + emerging-Home-Sleep-Apnea-CPAP-and-Respiratory-Therapy-Cycle + emerging-Patient-Direct-Home-Healthcare-Services + emerging-Home-Sleep-Apnea-CPAP-Recurring-Resupply-Cycle + emerging-Diabetes-Direct-Home-Delivery-Cycle + emerging-Home-Negative-Pressure-Wound-Therapy + emerging-Conservative-Debt-Paydown-Post-Spin-Off structural-tailwinds against Patient-Direct-Apria-Home-Health-Competitive-Pressure (AdaptHealth + Lincare-Linde + Aerogen + Quipt-Home-Medical + VieMed-Healthcare + Insulet + Dexcom + Tandem-Diabetes-Care + CCS-Medical-AdaptHealth-acquired + Edgepark-Medical-Supplies-Cardinal-Health-acquired) + emerging-Medicare-DME-Reimbursement-Pressure + emerging-Home-Sleep-Apnea-CPAP-Resupply-Cycle-Variability + emerging-Spin-Off-Process-Execution-Risk-2025-2026 + emerging-Diabetes-Direct-Home-Delivery-Margin-Pressure structural-headwinds. Patient-Direct-Apria-Post-Spin-Off-Leadership + multi-cycle-disciplined-Patient-Direct-Apria-Home-Health-and-Healthcare-Services-Capital-Management execution remains primary FY2026 multi-cycle-emerging value-creation lever.